Atlas Trials

Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study in Patients After Organ Transplantation

Clinical trial NCT05162456 · UNKNOWN

Trial details

NCT number
NCT05162456
Sponsor
Collegium Medicum w Bydgoszczy
Status
UNKNOWN
Study type
OBSERVATIONAL
SARS-CoV2 InfectionSARS-CoV2 Antibodies
Start date
2021-07-01
Primary completion
2023-02-28
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.